129 related articles for article (PubMed ID: 22830339)
61. Cytotoxic activity evaluation and QSAR study of chromene-based chalcones.
Firoozpour L; Edraki N; Nakhjiri M; Emami S; Safavi M; Ardestani SK; Khoshneviszadeh M; Shafiee A; Foroumadi A
Arch Pharm Res; 2012 Dec; 35(12):2117-25. PubMed ID: 23263805
[TBL] [Abstract][Full Text] [Related]
62. Synthesis of procyanidin B3 and its anti-inflammatory activity. the effect of 4-alkoxy group of catechin electrophile in the Yb(OTf)(3)-catalyzed condensation with catechin nucleophile.
Oizumi Y; Mohri Y; Hirota M; Makabe H
J Org Chem; 2010 Jul; 75(14):4884-6. PubMed ID: 20568787
[TBL] [Abstract][Full Text] [Related]
63. DFT-based QSAR models to predict the antimycobacterial activity of chalcones.
Barua N; Sarmah P; Hussain I; Deka RC; Buragohain AK
Chem Biol Drug Des; 2012 Apr; 79(4):553-9. PubMed ID: 22151277
[TBL] [Abstract][Full Text] [Related]
64. Synthetic chalcones as potential anti-inflammatory and cancer chemopreventive agents.
Won SJ; Liu CT; Tsao LT; Weng JR; Ko HH; Wang JP; Lin CN
Eur J Med Chem; 2005 Jan; 40(1):103-12. PubMed ID: 15642415
[TBL] [Abstract][Full Text] [Related]
65. Functional evaluation of synthetic flavonoids and chalcones for potential antiviral and anticancer properties.
Mateeva N; Eyunni SVK; Redda KK; Ononuju U; Hansberry TD; Aikens C; Nag A
Bioorg Med Chem Lett; 2017 Jun; 27(11):2350-2356. PubMed ID: 28442256
[TBL] [Abstract][Full Text] [Related]
66. Update on uses and properties of citrus flavonoids: new findings in anticancer, cardiovascular, and anti-inflammatory activity.
Benavente-García O; Castillo J
J Agric Food Chem; 2008 Aug; 56(15):6185-205. PubMed ID: 18593176
[TBL] [Abstract][Full Text] [Related]
67. Flavonoids, Breast Cancer Chemopreventive and/or Chemotherapeutic Agents.
Magne Nde CB; Zingue S; Winter E; Creczynski-Pasa TB; Michel T; Fernandez X; Njamen D; Clyne C
Curr Med Chem; 2015; 22(30):3434-46. PubMed ID: 26502949
[TBL] [Abstract][Full Text] [Related]
68. Chemoprotective mechanism of the natural compounds, epigallocatechin-3-O-gallate, quercetin and curcumin against cancer and cardiovascular diseases.
Jagtap S; Meganathan K; Wagh V; Winkler J; Hescheler J; Sachinidis A
Curr Med Chem; 2009; 16(12):1451-62. PubMed ID: 19355899
[TBL] [Abstract][Full Text] [Related]
69. Geriatric obesity: evaluating the evidence for the use of flavonoids to promote weight loss.
Hurt RT; Wilson T
J Nutr Gerontol Geriatr; 2012; 31(3):269-89. PubMed ID: 22888842
[TBL] [Abstract][Full Text] [Related]
70. Synthesis of novel carbazole chalcones as radical scavenger, antimicrobial and cancer chemopreventive agents.
Bandgar BP; Adsul LK; Lonikar SV; Chavan HV; Shringare SN; Patil SA; Jalde SS; Koti BA; Dhole NA; Gacche RN; Shirfule A
J Enzyme Inhib Med Chem; 2013 Jun; 28(3):593-600. PubMed ID: 22380776
[TBL] [Abstract][Full Text] [Related]
71. Design, synthesis and experimental validation of novel potential chemopreventive agents using random forest and support vector machine binary classifiers.
Sprague B; Shi Q; Kim MT; Zhang L; Sedykh A; Ichiishi E; Tokuda H; Lee KH; Zhu H
J Comput Aided Mol Des; 2014 Jun; 28(6):631-46. PubMed ID: 24840854
[TBL] [Abstract][Full Text] [Related]
72. Molecular and cellular targets.
Bode AM; Dong Z
Mol Carcinog; 2006 Jun; 45(6):422-30. PubMed ID: 16688728
[TBL] [Abstract][Full Text] [Related]
73. Dietary small molecules and large-scale gene expression studies: an experimental approach for understanding their beneficial effects on the development of malignant and non-malignant proliferative diseases.
Mariappan D; Winkler J; Parthiban V; Doss MX; Hescheler J; Sachinidis A
Curr Med Chem; 2006; 13(13):1481-9. PubMed ID: 16787199
[TBL] [Abstract][Full Text] [Related]
74. Anticancer Activity of Chalcones and Its Derivatives: Review and In Silico Studies.
Leite FF; de Sousa NF; de Oliveira BHM; Duarte GD; Ferreira MDL; Scotti MT; Filho JMB; Rodrigues LC; de Moura RO; Mendonça-Junior FJB; Scotti L
Molecules; 2023 May; 28(10):. PubMed ID: 37241750
[TBL] [Abstract][Full Text] [Related]
75.
Ali MS; Lee EB; Lee SJ; Lee SP; Boby N; Suk K; Birhanu BT; Park SC
Antioxidants (Basel); 2021 Aug; 10(8):. PubMed ID: 34439524
[TBL] [Abstract][Full Text] [Related]
76. Palladium-catalyzed coupling reactions on functionalized 2-trifluoromethyl-4-chromenone scaffolds. Synthesis of highly functionalized trifluoromethyl-heterocycles.
Izquierdo J; Jain AD; Abdulkadir SA; Schiltz GE
Synthesis (Stuttg); 2019 Mar; 51(6):1342-1352. PubMed ID: 31274934
[TBL] [Abstract][Full Text] [Related]
77. Exploratory conformational study of (+)-catechin. Modeling of the polarizability and electric dipole moment.
Bentz EN; Pomilio AB; Lobayan RM
J Mol Model; 2014 Dec; 20(12):2522. PubMed ID: 25431187
[TBL] [Abstract][Full Text] [Related]
78. Structure and electronic properties of (+)-catechin: aqueous solvent effects.
Bentz EN; Pomilio AB; Lobayan RM
J Mol Model; 2014 Feb; 20(2):2105. PubMed ID: 24526380
[TBL] [Abstract][Full Text] [Related]
79. In vitro and in vivo evaluation of novel anticancer agents in triple negative breast cancer models.
Johnson KP; Yearby LA; Stoute D; Burow ME; Rhodes LV; Gray M; Carriere P; Tilghman SL; McLachlan JA; Ochieng J
J Health Care Poor Underserved; 2013 Feb; 24(1 Suppl):104-11. PubMed ID: 23395947
[TBL] [Abstract][Full Text] [Related]
80. (Iso)flav(an)ones, chalcones, catechins, and theaflavins as anticarcinogens: mechanisms, anti-multidrug resistance and QSAR studies.
Mercader AG; Pomilio AB
Curr Med Chem; 2012; 19(25):4324-47. PubMed ID: 22830339
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
